<DOC>
	<DOCNO>NCT00563992</DOCNO>
	<brief_summary>This study evaluate effectiveness two different mood stabilize medication , lithium valproate , treat people bipolar disorder suicidal behavior .</brief_summary>
	<brief_title>Effectiveness Lithium Valproate Treating High-Risk Bipolar Disorder</brief_title>
	<detailed_description>Bipolar disorder , also call manic-depressive illness , brain disorder cause dramatic change person 's mood energy . Bipolar disorder normally form late adolescence early adulthood require treatment rest person 's life . People bipolar disorder undergo period extreme happiness extreme sadness , know episode mania depression . Symptoms mania include increase energy , euphoric mood , mind racing , aggressive behavior , substance abuse , poor decision making . Symptoms depression include persistent feeling anxiety , guilt , hopelessness ; irregular sleep appetite pattern ; lethargy ; disinterest previously enjoy activity ; excessive irritability restlessness ; inability concentrate . Some people bipolar disorder also become suicidal . Suicidal behavior likely occur onset illness , make vital recognize treat disorder early . Current treatment include mood stabilizing medication psychotherapy . This study evaluate effectiveness two different mood stabilize medication , lithium valproate , treat people bipolar disorder suicidal behavior . Participants double-blind study randomly assign take one two medication , either lithium valproate . In first 2 6 month , depend clinical condition , participant may also require take antidepressant paroxetine and/or medication olanzapine . Participants attend regular visit psychiatrist psychologist Neuroscience Clinic . A blood sample take visit monitor medication blood level . Participants also undergo periodic routine laboratory urine test assure safety . If psychiatrist feel improvement occur end 2- 6-month period , participant gradually take paroxetine and/or olanzapine 2-week period . They continue take assign lithium valproate remainder study . If psychiatrist feel condition worsen , participant prescribe new medication need . These medication include antidepressant ( bupropion venlafaxine ) antimanic antipsychotic drug ( perphenazine haloperidol ) . Once participant achieve least 2 week normal mood , gradually take prescribed medication remain take assigned lithium valproate . Participants achieve least 2 week normal mood stop study participation still offer clinical treatment . The remain participant take lithium valproate continue regular visit psychiatrist last 6 month study . The entire study last 12 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Current major depressive episode mixed episode Bipolar disorder History suicidal behavior Requires detoxification alcohol substance Blood pressure great 160/90 mm Hg Active medical problem Requires longterm antipsychotic maintenance Becomes manic mood stabilizer antidepressant Contraindication use lithium 1 valproate ( include failure respond ) Failure respond adequate trial paroxetine , bupropion , venlafaxine 2 year prior study entry Failure respond adequate trial olanzapine , haloperidol , perphenazine 2 year prior study entry Unable unwilling consent treatment Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>